chr1-53459817-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_033067.3(DMRTB1):ā€‹c.364C>Gā€‹(p.Gln122Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0003 in 1,445,566 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q122K) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00098 ( 0 hom., cov: 32)
Exomes š‘“: 0.00022 ( 1 hom. )

Consequence

DMRTB1
NM_033067.3 missense

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.275
Variant links:
Genes affected
DMRTB1 (HGNC:13913): (DMRT like family B with proline rich C-terminal 1) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in germ cell development; regulation of transcription by RNA polymerase II; and sex differentiation. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.004645616).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DMRTB1NM_033067.3 linkuse as main transcriptc.364C>G p.Gln122Glu missense_variant 1/4 ENST00000371445.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DMRTB1ENST00000371445.3 linkuse as main transcriptc.364C>G p.Gln122Glu missense_variant 1/41 NM_033067.3 P1

Frequencies

GnomAD3 genomes
AF:
0.000981
AC:
149
AN:
151878
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00287
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000525
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.000250
Gnomad OTH
AF:
0.00192
GnomAD3 exomes
AF:
0.000241
AC:
15
AN:
62254
Hom.:
0
AF XY:
0.000218
AC XY:
8
AN XY:
36760
show subpopulations
Gnomad AFR exome
AF:
0.00430
Gnomad AMR exome
AF:
0.000460
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000707
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000212
Gnomad OTH exome
AF:
0.000548
GnomAD4 exome
AF:
0.000220
AC:
285
AN:
1293578
Hom.:
1
Cov.:
31
AF XY:
0.000217
AC XY:
138
AN XY:
636688
show subpopulations
Gnomad4 AFR exome
AF:
0.00375
Gnomad4 AMR exome
AF:
0.000518
Gnomad4 ASJ exome
AF:
0.0000459
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000142
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000144
Gnomad4 OTH exome
AF:
0.000415
GnomAD4 genome
AF:
0.000980
AC:
149
AN:
151988
Hom.:
0
Cov.:
32
AF XY:
0.000955
AC XY:
71
AN XY:
74322
show subpopulations
Gnomad4 AFR
AF:
0.00287
Gnomad4 AMR
AF:
0.000524
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000250
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.000854
Hom.:
0
Bravo
AF:
0.00119
ExAC
AF:
0.000110
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 26, 2022The c.364C>G (p.Q122E) alteration is located in exon 1 (coding exon 1) of the DMRTB1 gene. This alteration results from a C to G substitution at nucleotide position 364, causing the glutamine (Q) at amino acid position 122 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
8.1
DANN
Benign
0.80
DEOGEN2
Benign
0.0021
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.098
N
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N
MutationTaster
Benign
1.0
N
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.44
N
REVEL
Benign
0.048
Sift
Uncertain
0.0030
D
Sift4G
Benign
0.69
T
Polyphen
0.0
B
Vest4
0.13
MutPred
0.19
Gain of sheet (P = 0.0073);
MVP
0.068
MPC
0.49
ClinPred
0.014
T
GERP RS
-2.9
Varity_R
0.067
gMVP
0.068

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs765450052; hg19: chr1-53925490; API